Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BDH IndustriesBOM:524828 +0.46%78 Net Margin % is 9.92% as of Mar. 2026, which is 8% below its 10-year median of 10.83. GuruFocus rates BOM:524828 with a GF Score™ of 78/100 and a GF Value™ of ₹391.10 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 961 Drug Manufacturers companies, BDH Industries ranks better than 67.74% on this metric.
Net margin is calculated as Net Income divided by its Revenue. BDH Industries's Net Income for the
three
months ended in Mar. 2026 was ₹28.8 Mil. BDH Industries's Revenue for the
three
months ended in Mar. 2026 was ₹290.3 Mil. Therefore, BDH Industries's net margin for the quarter that ended in Mar. 2026 was 9.92%.
The historical rank and industry rank for BDH Industries's Net Margin % or its related term are showing as below:
BOM:524828'
s Net Margin % Range Over the Past 10 Years
Min: 7.8 Med: 10.83 Max: 14.29
Current: 11.27
BOM:524828's Net Margin % is ranked better than 67.74% of 961
companies
in the Drug Manufacturers industry
Industry Median: 5.48
vs BOM:524828: 11.27
BDH Industries (BOM:524828) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
BDH Industries Net Margin % Related Terms
BDH Industries Net Margin % Historical Data
* Premium members only.
The historical data trend for BDH Industries's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BDH Industries's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BDH Industries Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BDH Industries's Net Margin % distribution charts can be found below:
* The bar in red indicates where BDH Industries's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BDH Industries (BOM:524828) has a Net Margin % of 9.92% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on BDH Industries and its competitors. This is near median its historical median of 10.83. Over the past decade, BDH Industries' Net Margin % has ranged from 7.80 to 14.29. According to the industry distribution chart, BDH Industries ranks #310 out of 961 companies in the Drug Manufacturers industry, placing it in the top 32.3%.
Is BDH Industries' Net Margin % too high?
BDH Industries' current Net Margin % of 9.92% is near median its 10-year median of 10.83. Over the past 10 years, this metric has ranged from a low of 7.80 to a high of 14.29. The Drug Manufacturers industry median Net Margin % is 5.48. BDH Industries' value of 9.92% is 81% above this industry median. Based on the distribution chart, BDH Industries ranks #310 out of 961 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, BDH Industries has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BDH Industries' Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BDH Industries ranks #310 out of 961 companies for Net Margin %. This puts BDH Industries in the upper half of its industry. The industry median Net Margin % is 5.48. BDH Industries' value of 9.92% is 81% above this benchmark. Historically, BDH Industries' own Net Margin % has ranged from 7.80 to 14.29 over the past decade. While the company's 10-year median is 10.83 vs. the industry median of 5.48, BDH Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.48, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BDH Industries's current Net Margin % of 9.92% is 81% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on BDH Industries and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BDH Industries's current Net Margin % is 9.92%, which is near median its own 10-year median of 10.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BDH Industries stock overvalued right now?
Based on GuruFocus' analysis, BDH Industries (BOM:524828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹391.10, compared to a current price of ₹581.35 — trading 48.6% above its estimated fair value. The current Net Margin % is 9.92%, which is near median its 10-year median of 10.83 and 81% above the Drug Manufacturers industry median of 5.48. BDH Industries' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For BDH Industries (BOM:524828), the current Net Margin % is 9.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BDH Industries (BOM:524828) Overvalued in 2026?
Based on GuruFocus' analysis, BDH Industries stock appears to be overvalued.
The current stock price of ₹581.35 is trading 48.6% above its estimated GF Value™ of ₹391.10.
GuruFocus considers BDH Industries to be Significantly Overvalued.
Key valuation signals for BOM:524828:
Net Margin %: 9.92% (near median its 10-year median of 10.83)
GF Value™: ₹391.10 vs. price of ₹581.35 (48.6% above fair value)
Industry Position: 81% above the Drug Manufacturers median (#310 of 961)
No single metric tells the full story. See the BOM:524828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BDH Industries Ltd is an India based pharmaceutical company. It is engaged in the manufacturing of therapeutic formulations including various pharmaceuticals. The company has the following reportable segments; Pharmaceuticals and Renewable Energy. The majority of its revenue is generated from the Pharmaceuticals segment. The company's product portfolio encompasses therapeutic categories including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antiulcerant, antimalarials, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, psychotropic, and others.
78GF Score
Get the complete analysis for BOM:524828
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524828 has been successfully added to your 
